What is BioSig Technologies, Inc.'s return on equity?

BioSig Technologies, Inc. (STEX) reported return on equity of -627.1% in Q1 2026.

What is the long-term trend for BioSig Technologies, Inc.'s return on equity?

Over 2 years (2020 to 2022), BioSig Technologies, Inc.'s return on equity has grown at a 21.1% compound annual growth rate (CAGR), from -294% to -431%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

BioSig Technologies, Inc. STEX Return on equity

Return on equity at other companies

Tradeweb Markets Inc.TW

13.8%+4.7pp

Bit DigitalBTBT

-38.2%+67.7pp

DigitalBridge GroupDBRG

7.3%+1.0pp

StoneX Group Inc.SNEX

20.2%+2.9pp

TEC

Bio-TechneTECH

6.5%-3.9pp

Boston ScientificBSX

14.8%+5.2pp

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-61.8%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Calculated from BioSig Technologies, Inc.’s reported figures.

net income/total stockholders equity=-627.1%

Based on trailing twelve months.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s return on equity?: BioSig Technologies, Inc. (STEX) reported return on equity of -627.1% in Q1 2026.
What is the long-term trend for BioSig Technologies, Inc.'s return on equity?: Over 2 years (2020 to 2022), BioSig Technologies, Inc.'s return on equity has grown at a 21.1% compound annual growth rate (CAGR), from -294% to -431%.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.